Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
Company Announcements
Bright Minds Biosciences Strengthens Advisory Board with PWS Experts
4d ago
DRUG
Premium
Ratings
Bright Minds Biosciences: Strategic Advancements in Serotonergic Therapies and Expansion into Prader-Willi Syndrome
11d ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences Launches New Prader-Willi Syndrome Program
14d ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences to Present at Key Healthcare Conferences and Grants Equity Incentives
14d ago
DRUG
Premium
The Fly
Bright Minds price target raised to $82 from $75 at Baird
14d ago
DRUG
Premium
The Fly
Psychedelic: Compass Pathways, GH Research report Q3 earnings
15d ago
PBM
ATAI
Premium
Company Announcements
Bright Minds Biosciences Advances Epilepsy Treatment with BMB-101 Study
25d ago
DRUG
Premium
Ratings
Bright Minds Biosciences’ Promising Pipeline and Strategic Expansion Justify Buy Rating
2M ago
DRUG
Premium
The Fly
Psychedelic: Cybin completes enrollment in CYB004 Phase 2 study
2M ago
CYBN
DRUG
Premium
The Fly
Bright Minds initiated with a Buy at BTIG
2M ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences Launches $100 Million At-The-Market Offering
3M ago
DRUG
Premium
The Fly
Psychedelic: Bright Minds reports preclinical BMB-201 results
3M ago
CMPS
CYBN
Premium
The Fly
Bright Minds says BMB-201 outperforms sumatriptan in preclinical model
3M ago
DRUG
Premium
Ratings
Bright Minds Biosciences: Advancing Breakthrough Epilepsy Treatment with BMB-101 and Strong Financial Position
3M ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences Reports Q3 2025 Financial Results
3M ago
6K
DRUG
Premium
The Fly
Psychedelic: atai Life Sciences, Cybin report earnings results
3M ago
ATAI
CYBN
Premium
The Fly
Psychedelic: atai Life Sciences, Beckley Psytech report BPL-003 study results
5M ago
ATAI
CMND
Premium
The Fly
Bright Minds assumed with an Overweight at Cantor Fitzgerald
5M ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences to Present at 2025 Jefferies Global Healthcare Conference
6M ago
DRUG
Premium
Ratings
Bright Minds Biosciences’ BMB-101: A Promising Breakthrough in Treatment-Resistant Epilepsy
6M ago
DRUG
Premium
Ratings
Bright Minds Biosciences: Buy Rating Issued on Promising Potential of BMB-101 for Absence Seizures
6M ago
DRUG
Premium
Company Announcements
Bright Minds Biosciences Hosts Virtual R&D Day on Absence Epilepsy
6M ago
DRUG
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
